GlassScriptPhysician profile
Adam Tullis
NPI 1972912657
$4,489.36
in general payments reported to CMS, 2019-2025
11 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,324 · 2020: $341 · 2021: $523 · 2022: $95.67 · 2023: $745 · 2024: $347 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $674 · Food and Beverage: $532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $673.68 |
| Food and Beverage | $532.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,788.96 | 2019-2023 | Axs Infinity Ls |
| Anika Therapeutics, INC. | $819.37 | 2021-2023 | Ovomotion |
| Osteomed LLC | $792.87 | 2019 | |
| Exactech, INC. | $409.26 | 2024-2025 | |
| Organogenesis INC. | $154.59 | 2020 | |
| Sanara Medtech INC. | $139.11 | 2021 | |
| Heron Therapeutics, INC. | $121.84 | 2021 | |
| Bioventus LLC | $116.18 | 2021 | |
| Imbed Biosciences INC. | $80.91 | 2022 | |
| Fusion Orthopedics USA, LLC | $51.51 | 2024 | |
| Bone Support INC. | $14.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Tullis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.